ERIKA WHETZEL: Open Payments
NPI 1306169933 · CHARLOTTESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 19 payments from 8 companies in 2025. Trend: 2023 $18 · 2024 $401 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $113 |
| ABBVIE INC. | 3 | $76 |
| Neurocrine BioSciences, Inc. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: UZEDY, VRAYLAR, INGREZZA, CAPLYTA, INVEGA SUSTENNA, Auvelity, FANAPT, REXULTI.
Industry payments across VA — which companies pay providers there.
